Published in Exp Eye Res on October 01, 1980
Beta adrenergic receptors in pigmented ciliary processes. Br J Ophthalmol (1982) 0.88
The adenylate cyclase receptor complex and aqueous humor formation. Yale J Biol Med (1984) 0.77
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry (1983) 8.71
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Pathological verification of ischemic score in differentiation of dementias. Ann Neurol (1980) 5.25
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79
The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol (1990) 3.57
Fine structure and electrolyte analyses of cerebral edema induced by alkyl tin intoxication. J Neuropathol Exp Neurol (1963) 3.43
Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04
Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol (1976) 2.62
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Life span and synapses: will there be a primary senile dementia? Neurobiol Aging (2001) 2.55
Senile dementia of the Alzheimer type. Ann Neurol (1983) 2.47
Alzheimer's disease. N Engl J Med (1986) 2.37
Self-perceived health and 5-year mortality risks among the elderly in Shanghai, China. Am J Epidemiol (1998) 2.14
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
A simple constant-infusion manometric test for measurement of CSF absorption. I. Rationale and method. Neurology (1970) 2.11
Studies of the mode of action of adrenal steroids on lymphocytes. Recent Prog Horm Res (1967) 2.09
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature (1980) 2.02
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology (1998) 1.96
Women, myocardial infarction, and dementia in the very old. Neurology (1990) 1.94
Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol (1994) 1.90
Neurobiology of autism. Ann Neurol (1998) 1.78
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78
Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol (1973) 1.77
Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology (2002) 1.74
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology (1996) 1.64
Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology (1997) 1.58
Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol (1989) 1.55
Properties of adenylate cyclase of lymphoid cells. Proc Natl Acad Sci U S A (1971) 1.47
Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. Proc Natl Acad Sci U S A (1972) 1.41
Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36
Influence of cortisol on the utilization of precursors of nucleic acids and protein by lymphoid cells in vitro. J Biol Chem (1968) 1.36
Alterations in protein and nucleic acid metabolism of thymocytes produced by adrenal steroids in vitro. J Biol Chem (1966) 1.31
Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol (1982) 1.27
3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier. Life Sci (1975) 1.26
Cross-cultural studies of dementia. A comparison of mini-mental state examination performance in Finland and China. Arch Neurol (1989) 1.23
Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol (1994) 1.23
Clinical and neuropathological findings in Lewy body dementias. Brain Cogn (1996) 1.23
Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke (1977) 1.22
Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22
School eye health appraisal. Indian J Ophthalmol (1990) 1.21
Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells. Proc Natl Acad Sci U S A (1971) 1.20
Opioid and opiate immunoregulatory processes. Crit Rev Immunol (1996) 1.19
Adenyl cyclase of cultured mammalian cells: activation by catecholamines. Science (1970) 1.19
A simple constant-infusion manometric test for measurement of CSF absorption. II. Clinical studies. Neurology (1970) 1.16
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol (2000) 1.15
Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc (1995) 1.14
Studies concerning the interaction of serine soluble ribonucleic acid with seryl soluble ribonucleic acid synthetase from baker's yeast. Biochemistry (1966) 1.14
Evidence for induction by cortisol in vitro of a protein inhibitor of transport and phosphorylation processes in rat thymocytes. Proc Natl Acad Sci U S A (1971) 1.08
ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China. J Am Geriatr Soc (1995) 1.07
Syndrome of normal pressure hydrocephalus: possible relation to hypertensive and arteriosclerotic vasculopathy. J Neurol Neurosurg Psychiatry (1977) 1.07
Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Ann Neurol (1984) 1.05
Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier. J Neurochem (1975) 1.04
Cognitive impairment among elderly adults in Shanghai, China. J Gerontol (1989) 1.03
Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci U S A (1993) 1.03
Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks? Neurology (1996) 1.02
Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions. Brain Res (1971) 1.00
Adenosine 3',5'-monophosphate-dependent protein kinase of cultured mammalian cells. Science (1971) 0.99
Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 0.99
Maintenance of a constant brain extracellular potassium. Fed Proc (1976) 0.98
Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A (1993) 0.96
The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology (1994) 0.96
Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res (1995) 0.96
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Ann Neurol (1996) 0.96
Neuronal pigments: spectroscopic characterization of human brain melanin. J Neurochem (1978) 0.96
Exchange of cerebrospinal fluid potassium with blood and brain. Study in normal and Ouabain perfused cats. Arch Neurol (1965) 0.96
Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Ann Neurol (1982) 0.95
K 42 distribution in brain during simultaneous ventriculocisternal and subarachnoid perfusion. Brain Res (1972) 0.95
Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells. J Cell Physiol (1979) 0.94
Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts. Arch Neurol (1989) 0.94
Resolution of cytidine- and adenosine- terminal transfer ribonucleic acids. Biochemistry (1966) 0.94
Expression of adenylate cyclase, catecholamine receptor, and cyclic adenosine monophosphate-dependent protein kinase in synchronized culture of Chang's liver cells (S phase-membrane receptors-NaF stimulation). Proc Natl Acad Sci U S A (1972) 0.94
Differential diagnosis of dementing illnesses. Neurol Clin (1986) 0.94
Ionic interaction of sulfatide with choline lipids. Science (1968) 0.94
Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink". Neurology (1974) 0.94
Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures. Brain Res (1987) 0.93
A preliminary analysis of incidence of dementia in Shanghai, China. Psychiatry Clin Neurosci (1998) 0.93
Cross-cultural and multi-ethnic dementia evaluation by mental status and memory testing. Cortex (1988) 0.93
Normal pressure hydrocephalus. Contemp Neurol Ser (1977) 0.92
The cherry-red spot--myoclonus syndrome. Ann Neurol (1978) 0.92
Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina. J Neurochem (1973) 0.92
Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease. Ann N Y Acad Sci (1997) 0.92
Nutritional anemia in an inner-city community. Relationship to age and ethnic group. JAMA (1972) 0.91
Interaction of pergolide with central dopaminergic receptors. Proc Natl Acad Sci U S A (1980) 0.91
In vivo action of enzyme-activated irreversible inhibitors of glutamic acid decarboxylase and gamma-aminobutyric acid transaminase in retina vs. brain. J Pharmacol Exp Ther (1986) 0.91
Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. Proc Natl Acad Sci U S A (1974) 0.91
Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology (1991) 0.90
The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain. J Pharmacol Exp Ther (1981) 0.90
Biochemical analysis of mutants of a macrophage cell line resistant to the growth-inhibitory activity of interferon. J Cell Biol (1984) 0.90
Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cells. Biochem Biophys Res Commun (1972) 0.89
Teaching the multidisciplinary team approach in a geriatrics miniresidency. Acad Med (1990) 0.89
Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid beta-protein precursor involved? Ann Neurol (1989) 0.89
Inhibitory effects of cortisol and antibiotics on substrate entry and ribonucleic acid synthesis in rat thymocytes in vitro. J Biol Chem (1970) 0.89
Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Ann N Y Acad Sci (2000) 0.89
Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol (1992) 0.89
The reactions of cations with aqueous dispersions of phosphatidic acid. Determination of stability constants. Biochemistry (1966) 0.88
Can late life social or leisure activities delay the onset of dementia? J Am Geriatr Soc (1995) 0.88